The QualityStocks Daily Stock List
- Covalon Technologies Ltd. (CVALF)
- Scientific Industries, Inc. (SCND)
- EPHS Holdings, Inc. (STNN)
- Wildflower Brands, Inc. (WLDFF)
- Grupo TMM, S.A.B. (GTMAY)
- Bespoke Extracts, Inc. (BSPK)
- NanoVibronix, Inc. (NAOV)
- BioElectronics Corporation (BIEL)
- Exicure, Inc. (XCUR)
- EnviroLeach Technologies, Inc. (EVLLF)
- PetroShare Corp. (PRHR)
- Tempus Applied Solutions Holdings, Inc. (TMPS)
- Nanophase Technologies Corp. (NANX)
- CurAegis Technologies, Inc. (CRGS)
Covalon Technologies Ltd. (CVALF)
OTC Markets, TradingView, InvestorsHangout, Proactive Investor, Penny Stock Picks, Penny Stock Tweets, Stockhouse, Barchart, Wallet Investor, 4-Traders, InvestorsHub, CapitalCube, and Stockwatch reported earlier on Covalon Technologies Ltd. (CVALF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Covalon Technologies Ltd. is an advanced medical technologies company headquartered in Mississauga, Ontario. Covalon researches, develops and commercializes new healthcare technologies. The Company’s patented technologies, products and services address the advanced healthcare needs of medical device companies, healthcare providers and individual consumers. Covalon Technologies lists on the OTC Markets Group’s OTCQX.
The Company has established a Special Committee of the Board of Directors to evaluate potential acquisitions, strategic alliances, and partnerships. This is in response to the interest generated following its earlier announcement of its $100 million contract awards in the Middle East.
Covalon’s technologies are used to prevent, detect and manage medical conditions in specialty areas such as wound care, tissue repair, infection control, disease management, medical device coatings and biocompatibility. The Company’s Advanced Wound Care line has been specially designed for the successful treatment of a wide assortment of wounds.
Concerning Infection Prevention, Covalon Technologies has its highly lubricious and top-quality antimicrobial protection SilverCoat™ Foley catheter. Furthermore, the Company has its dual antimicrobial silicone adhesive platform across the MediClear™ PreOp, SurgiClear™ and IV Clear™ brands.
Covalon’s Perioperative Care brands, MediClear™ and SurgiClear™ offer a range of care throughout a patient’s surgical journey. Covalon has its Technology platforms. These are its Biomatrix Platform, its Antimicrobial Silicone Platform, as well as its Medical Coating Platform.
At the beginning of October, Covalon Technologies announced that it closed the acquisition of AquaGuard, the Seattle, Washington-headquartered division of medical technologies company Cenorin, LLC. AquaGuard's specialized products provide patients with important moisture protection for wound, surgical, and vascular access sites throughout the body while showering.
AquaGuard's family of products provide protection for sites and dressings all over the body. Moreover, they can be applied by most patients without the need of assistance from medical professionals. Covalon Technologies acquired all of the assets and staff dedicated to the AquaGuard business from Cenorin, LLC.
Covalon Technologies Ltd. (CVALF), closed Friday's trading session at $3.62, up 11.38%, on 4,600 volume with 7 trades. The average volume for the last 3 months is 3,382 and the stock's 52-week low/high is $2.55/$7.12.
Scientific Industries, Inc. (SCND)
Amigo Bulls, Zacks, Wallet Investor, Simply Wall St, Proactive Investors, Marketbeat, 4-Traders, MicroSmallCap, InvestorsHub, and The Street reported previously on Scientific Industries, Inc. (SCND), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Scientific Industries, Inc. designs, manufactures, and markets an array of laboratory equipment. These include the world-renowned Vortex-GenieÒ 2 Mixer and TorbalÒ balances. Additionally, the Company produces and sells customized catalyst research instruments. It also engages in the research, development and production of bioprocessing systems and methods. OTCQB-listed, Scientific Industries is based in Bohemia, New York.
The Company’s products are typically used and designed for research purposes in laboratories of universities, hospitals, pharmaceutical companies, chemical companies, and medical device manufacturers. Scientific Industries offers vortex mixers to mix the contents of test tubes, beakers, and other containers by placing such containers on a rotating cup or other attachments. In addition, it offers various mixers and shakers, such as high-speed touch mixers, cell disruptors, microplate mixers, and vortex mixers incorporating digital control and display, among others.
Scientific Industries also provides bioprocessing systems consisting of coaster systems using disposable sensors for vessels with volumes ranging from 250 milliliter to 5 liters. The Company also provides mechanical balances, moisture analyzers, and force gauges. Moreover, it offers pharmacy, laboratory, and industrial digital scales.
Furthermore, the Company provides benchtop multi-purpose rotators and rockers to rotate and rock different containers. Scientific Industries also provides refrigerated incubators and incubator shakers; magnetic stirrers, and large volume magnetic and four-place general purpose stirrers in analog and digital versions, among others.
This past November, Scientific Industries, for the three months ended September 30, 2018, reported Net Income of $142,000 ($.10 per basic share) versus a Net Loss of $232,600 ($.16 loss per basic share). The Company reported Revenues of $2,038,600 versus Revenues of $1,280,800 for the three months ended September 30, 2018 and 2017, respectively.
In November, the Company reported that during the current period, Revenues rose by $757,800 (59 percent). The increase in Revenues was mainly because of increases in sales of benchtop laboratory equipment, catalyst research instruments, and bioprocessing systems royalties, of $492,500, $188,800 and $76,500, respectively.
Scientific Industries, Inc. (SCND), closed Friday's trading session at $3.71, even for the day, on 4,500 volume with 8 trades. The average volume for the last 3 months is 329 and the stock's 52-week low/high is $2.96/$4.30.
EPHS Holdings, Inc. (STNN)
MarketWatch, Street Insider, Market Chameleon, Stockwatch, InvestorsHub, GuruFocus, Dividend Investor, last10k, Simply Wall St, Stockopedia, The Stock Market Watch, The Street, Wallet Investor, Morningstar, Marketbeat, and YCharts reported on EPHS Holdings, Inc. (STNN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
EPHS Holdings, Inc., by way of its subsidiary, Emerald Plants Health Source, Inc., intends to cultivate and distribute cannabis in Canada. The Company’s intention is to secure a commercial cultivation license identified as a license for access to cannabis for medical purposes regulation (ACMPR). EPHS Holdings has its head office in Boynton Beach, Florida. The Company’s shares trade on the OTC Markets Group’s OTCQB.
Only upon receipt of the ACMPR may EPHS Holdings begin its commercial operations. After Health Canada grants the Company its ACMPR license, EPHS will start cultivation of its initial cannabis crops. The first crops will be submitted to Health Canada as part of EPHS’s application for a sales license. The Company plans to commence commercial sales within four months of receiving the ACMPR license.
Emerald Plants Health Source is EPHS Holdings’ sole operating subsidiary. Emerald is headquartered in the Province of Quebec and conducts its operations entirely within Canada. Upon Emerald obtaining its ACMPR, it will be required to apply for an additional sales license.
Last week, EPHS Holdings announced the signing of a binding Letter of Intent (LOI) to acquire 100 percent of the issued and outstanding shares of privately held Merritt Valley Cannabis (a Canadian corporation) in a non-cash transaction. The Company also announced the appointment of Mr. Stevan Perry as the Company’s President. Mr. Perry is a senior executive and business development leader. He has more than 18 years of corporate, operational and project management experience.
EPHS Holdings’ Chief Executive Officer, Mr. Gianfranco Bentivoglio, said, "The commercial cultivation market of cannabis for CBD and THC related products is explosive and the timing of our acquisition could not be better. With Stevan's history in the industry and his expertise in energy efficiency, the ability to be both a strong producer in the sector, will position the company to be one of the lowest cost producers in industry delivering maximum value to our shareholders.”
EPHS Holdings, Inc. (STNN), closed Friday's trading session at $1.15, up 4.55%, on 850 volume with 4 trades. The average volume for the last 3 months is 6,332 and the stock's 52-week low/high is $0.15/$4.40.
Wildflower Brands, Inc. (WLDFF)
StocksNewsFeed, Stockhouse, InvestorPlace, Morningstar, Dividend Investor, Investors Hangout, Barchart, The Hot Penny Stocks, Jet Life Penny Stocks, Stockwatch, Micro Small Cap, Emerging Growth, Penny Stock Hub, MarketWatch, Wallmine, GuruFocus, Market Screener, Midas Letter, InvestorsHub, TradingView, and The Street reported earlier on Wildflower Brands, Inc. (WLDFF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Wildflower Brands, Inc. is centering on building reputable brands and quality products that incorporate the synergistic effects of plants and their extracts. The Company formerly went by the name Wildflower Marijuana, Inc. It changed its corporate name to Wildflower Brands, Inc. in April 2018. OTCQB-listed, Wildflower Brands is based in Vancouver, British Columbia.
Wildflower’s mission is to connect people with the healing power of plants. The Company develops its products through listening to the mature cannabis-smart consumers and experienced dispensary bud tenders’ feedback. Wildflower works to find the best technologies, use the highest quality cannabis, and pair it with the most synergistic ingredients to maximize the benefits of cannabis.
The Company offers a complete line-up of wellness focused cannabis infused products. All of its products are made in America by Wildflower in its GMP certified facilities and third-party lab tested for quality assurance and accurate labeling.
The Company has its Wildflower by Bridges General branded stores. Wildflower by Bridges General branded stores will feature the Company’s existing online catalog of products. In addition, they will feature in-store only exclusive products designed specifically for the New York market. Bridges General is a unique retail concept by Wildflower’s partner Retail Worx. The first three locations include 11 Times Square; 770 Broadway; and 11 Madison Avenue.
Recently, Wildflower Brands announced that it received a Memorandum of Understanding (MOU) with one of the top cannabis delivery technology companies in the State of California. The MOU is the initial step for Wildflower to activate delivery from the California licenses, which were acquired earlier in 2018. Wildflower’s intention is to serve the western part of the Los Angeles area.
Last week, Wildflower Brands announced greater than $1M in sales in its first quarter, versus $103,893 in Q1 of the prior year. Sales from all sources are up from the prior quarter. The largest increase came from sales to health and wellness retailers across the U.S. This marks the 9th consecutive quarter of increased revenue.
Wildflower Brands, Inc. (WLDFF), closed Friday's trading session at $0.5851, up 2.65%, on 10,872 volume with 13 trades. The average volume for the last 3 months is 22,538 and the stock's 52-week low/high is $0.0099/$1.139.
Grupo TMM, S.A.B. (GTMAY)
Amigo Bulls, Stockhouse, Zacks, CapitalCube, YCharts, Wallet Investor, Last10k, TradingView, Penny Stock Tweets, Marketbeat, The Street, OTC Markets, Penny Stock Picks, VentureLine, and Stockwatch reported earlier on Grupo TMM, S.A.B. (GTMAY), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Grupo TMM, S.A.B. is a Mexican Maritime-management transportation and logistics Company. Grupo TMM operates together with its subsidiaries in Mexico and it operates in four segments. These are Maritime, Logistics, Ports and Terminals, and Warehousing. Grupo TMM is based in Mexico City, Mexico and the Company lists on the OTC Markets’ OTCQB.
Grupo TMM provides maritime transportation services. This includes offshore vessels that provide transportation and other services to the Mexican offshore oil industry. In addition, the Company provides tankers that transport petroleum products in Mexican waters; parcel tankers that transport liquid chemical and vegetable oil cargos from and to the United States and Mexico; and tugboats that provide towing services at the port of Manzanillo, Mexico.
As of March 31, 2018, Grupo TMM operated through a fleet of 39 vessels. These include product and chemical tankers, harbor tugs, and varied offshore supply vessels.
Grupo TMM also provides dry bulk carriers that transport unpackaged commodities, including steel between South America, the Caribbean, and Mexico. Moreover, the Company provides ship repair services through two floating drydocks. Grupo TMM also offers logistics services; logistics network analysis; logistics information process design; intermodal transport; and supply chain and logistics management.
Furthermore, the Company provides port agent services to vessel owners and operators in Mexican ports; and warehousing and bonded warehousing facility management services. Additionally, Grupo TMM operates the Tuxpan, Tampico, and Acapulco port facilities. It also offers product handling and repackaging; local pre-assembly; container maintenance and repair; and inbound and outbound distribution to automobile manufacturers and retailers.
In late October, Grupo TMM reported its financial results for Q3 2018. 2018 Q3 results include Accumulated Operating Profit of $1,166.2 million, a Debt decrease of $296.4 million, and $2,238.8 million Stockholders’ Equity.
Mr. José F. Serrano, Grupo TMM Chairman and Chief Executive Officer, said, “As a result of its proven experience Grupo TMM has continued adapting to the new condition of national and international markets, taking advantage of its effective client diversification strategy, cost optimization and revenue improvement. We have also developed new strategies to improve performance in each business unit, and exploit the gradual energy sector reactivation in México…”
Grupo TMM, S.A.B. (GTMAY), closed Friday's trading session at $1.90, up 21.02%, on 10,474 volume with 19 trades. The average volume for the last 3 months is 2,351 and the stock's 52-week low/high is $0.59/$1.83.
Bespoke Extracts, Inc. (BSPK)
Ventureline, Stockopedia, Investors Hangout, Wallet Investor, Infront Analytics, YCharts, Morningstar, Market Exclusive, Simply Wall St, Stockhouse, Marketwired, MarketWatch, and Wallmine reported earlier on Bespoke Extracts, Inc. (BSPK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Bespoke Extracts, Inc. is a producer of high quality, flavorful, hemp-derived cannabidiol (CBD) extract products. The Company established in early 2017 to introduce a proprietary line of premium quality, all-natural CBD products in the form of tinctures and capsules for the nutraceutical and veterinary markets. OTCQB-listed, Bespoke Extracts is headquartered in Sunny Isles Beach, Florida.
Bespoke’s products are produced using pure, all natural, zero-THC phytocannabinoid-rich (PCR) hemp-derived CBD. CBD is non-psychoactive. The Company’s products are marketed as dietary supplements and distributed through Bespoke’s direct-to-consumers ecommerce store.
The Company strives to use only vegan, Fair Trade Certified, and organic ingredients with fast acting benefits for anyone looking for an alternative remedy. Bespoke Extracts’ focus is on premium ingredients. The Company’s farmers have been innovators in hemp agriculture, farming practices, agrotech, and production for generations. Bespoke’s hemp is stable, high in CBD, low in THC, and resistant to pathogens and pests.
The Company’s products include Sport Lemon Lime Tincture – THC Free 1500MG; CBD Manuka Honey Tincture; and CBD Bacon Flavored Pet Tincture. In addition, products include CBD Softgel Capsules; CBD Pain Relief Cream; and CBD Isolate Powder.
Bespoke Extracts announced in July 2018 that it signed an agreement with Seidman Food Brokerage (SFB), providing for SFB to market Bespoke Extract’s proprietary CBD tinctures, lotions, and salves to greater than 1,500 stores located in Alabama, Florida, Georgia, North Carolina, South Carolina, Tennessee, The Bahamas and Puerto Rico.
Last month, Bespoke Extracts announced that Grammy-nominated, American Hip Hop superstar Soulja Boy Tell Em (Soulja Boy) signed a deal with the Company to collaborate on the development of a co-branded line of high quality CBD products. Soulja Boy will also proactively market and publicly endorse Bespoke Extracts’ complete proprietary line of CBD products to his huge social media fan base.
This week, Bespoke Extracts congratulated Hairy Kiwi/Bespoke CBD-sponsored rookie Mr. Sean Dylan Kelly for winning the 35th Annual Race of Champions in his debut appearance at Daytona International Speedway. Mr. Kelly lapped the second finisher.
Mr. Kelly said, "Thanks to Bespoke CBD’s sponsorship and Robertino Pietri and EJ Viso for all the coaching and support, I was given the opportunity to win one of the most prestigious motorcycle races on the planet. I’m very grateful.”
Bespoke Extracts, Inc. (BSPK), closed Friday's trading session at $0.06, up 3.45%, on 100,290 volume with 15 trades. The average volume for the last 3 months is 134,691 and the stock's 52-week low/high is $0.025/$3.00.
NanoVibronix, Inc. (NAOV)
Zacks, InvestorsHub, and MarketWatch reported on NanoVibronix, Inc. (NAOV), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
OTC BB-listed, NanoVibronix, Inc. is a medical device company using its proprietary and patented low intensity surface acoustic wave technology. The Company’s pioneering technology allows for the creation of low-frequency ultrasound waves, which can be used for an array of medical applications, including the disruption of biofilms and bacteria colonization, and also providing pain relief. NanoVibronix has its headquarters in Elmsford, New York. The Company’s Research and Development (R&D) is in Nesher, Israel.
NanoVibronix’s products include PainShield®, UroShield™, NG-Shield™, and WoundShield™. These devices can undergo administration at home, without the aid of medical professionals. The PainShield® device is a wearable, battery powered electronic unit. It uses a disposable patch through which it delivers localized energy creating therapeutic effect to relieve localized pain and stimulate soft tissue healing.
The UroShield™ system is a multi-targeting solution. Its intention is to work against several factors, which are vital in preventing catheter related complications. The NG-Shield™ utilizes the Company’s proprietary acoustic technology onto the Nasogastric tube in such a way that it noticeably decreases the trauma and effective friction of the tube and blocks tube associated pain and discomfort.
The WoundShield™ system is a novel, patch-based therapeutic ultrasound device. It facilitates soft tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. The WoundShield™ may also be used to enhance oxygen and topical drugs delivery. In December 2016, NanoVibronix announced that it received clearance to sell the WoundShield™ in Canada.
This past March, NanoVibronix announced that it was granted a patent by the United States Patent and Trademark Office (USPTO) entitled, "System and Method for Surface Acoustic Wave Treatment of Skin," with a term through 2033, which does not include regulatory extensions.
The Company’s Surface Acoustic Wave (SAW) technology employs a portable patch-based therapeutic device to facilitate soft tissue regeneration by producing ultrasound surface acoustic waves on the skin to increase local capillary perfusion and tissue oxygenation. The surface acoustic waves extend beyond the skin contact area of the device. Therefore, this allows treatment of infected skin areas without painful contact between the device and the infected area.
Recently, NanoVibronix announced successful interim trial results for UroShield™. The trial was conducted at two skilled nursing facilities near Buffalo, New York, in which 22 subjects underwent evaluation.
Mr. Brian Murphy, NanoVibronix Chief Executive Officer, said, "We are very excited to report the results of this latest study, which reinforces our earlier pre-clinical data demonstrating a significant reduction in bacterial colonization on catheter devices when using UroShield™.”
NanoVibronix, Inc. (NAOV), closed Friday's trading session at $3.40, up 1.49%, on 5,321 volume with 8 trades. The average volume for the last 3 months is 3,732 and the stock's 52-week low/high is $2.81/$5.00.
BioElectronics Corporation (BIEL)
Microcap Daily, Street Register, Stockhouse, MarketWatch, Investors Hangout, StreetInsider, Barchart, Biospace, Central Charts, Pink Investing, Uptick Newswire, Wallet Investor, Emerging Growth, Clay Trader, InvestorsHub, Market Screener, and Morningstar reported previously on BioElectronics Corporation (BIEL), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
BioElectronics Corporation is a leader in non-invasive electroceuticals. The Company is the maker of an industry leading family of disposable, drug-free, pain therapy devices. BioElectronics’ innovative medical devices safely and effectively treat chronic and acute pain through a unique mechanism of non-invasive sub-sensory neuromodulation. BioElectronics is headquartered in Frederick, Maryland.
The Company’s products include RecoveryRx® and ActiPatch. RecoveryRx® uses pulsed electromagnetic therapy to reduce pain and inflammation resulting in accelerated patient recovery and improved comfort. For medical professionals, the RecoveryRx® medical device provides a safe and cost-effective pain management therapy.
ActiPatch® provides advanced long-lasting chronic pain relief using Electromagnetic Pulse Therapy. It is a new and clinically proven drug free technology in the fight against chronic pain.
Additionally, Bioelectronics’ products include Smart Insole™, Allay® Menstrual Pain Relief, and HealFast® Veterinary Pain Relief. The Smart Insole™ consists of Electro-Pulse micro medical devices. These are embedded in comfortable heel gel inserts.
HealFast® Therapy is a drug-free therapy for horses, cats and dogs. It lessens swelling and pain while it speeds up healing of muscle and tendon injuries, sores, and incisions. Allay® is an award-winning drug-free micro medical device. It uses Electromagnetic Pulse Therapy to reduce menstrual pain and discomfort.
Recently, BioElectronics announced that Mundipharma Pty Limited added the ActiPatch® Musculoskeletal Pain Therapy medical device to its pain management portfolio. This was through acquiring the distribution rights in South East Asia, for Singapore, Malaysia, Thailand, Indonesia and the Philippines.
Also recently, BioElectronics announced that the U.S. Food & Drug Administration (FDA) declined the Company’s 510(k) submission for ActiPatch®, intended for seeking expanded over-the-counter (OTC) indications for the treatment of musculoskeletal pain. In the back pain study submitted to the FDA as clinical evidence, the ActiPatch was found to have a major treatment effect in women, but only a mild treatment effect in men.
Since gender differences in treatment effects were not identified in prior ActiPatch clinical studies (knee and plantar fasciitis pain), the FDA concluded that the clinical evidence in the present 510(k) application was “not substantially equivalent” to the prior evidence.
BioElectronics Corporation (BIEL), closed Friday's trading session at $0.0008, even for the day, on 17,418,687 volume with 20 trades. The average volume for the last 3 months is 63,770,507 and the stock's 52-week low/high is $0.0005/$0.005.
Exicure, Inc. (XCUR)
Penny Stock Hub, Insider Monkey, BioPortfolio, OTC Markets, Street Insider, MarketWatch, Business Wire, Stockopedia, 4-Traders, Stockwatch, Simply Wall St, TradingView, AdisInsight, Investors Hangout, Wallet Investor, Open Insider, Insider Mole, and Interactive Brokers reported previously on Exicure, Inc. (XCUR), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Exicure, Inc. is a clinical stage biotechnology company based in Chicago, Illinois. The Company is developing a new class of immunomodulatory and gene regulating drugs against validated targets. Exicure's lead programs center on oncology, inflammatory diseases, as well as genetic disorders. Exicure lists on the OTC Markets Group’s OTCQB.
Exicure's intellectual property (IP) portfolio includes greater than 140 pending patent applications and more than 55 allowed or issued patents. These filings encompass a range of inventions, including fundamental nanoparticle manufacturing breakthroughs and numerous application-specific improvements.
Concerning Partnering and Licensing, the Company's strategy is to maximize the potential of its Spherical Nucleic Acid (SNA) technology platform through in-house development, collaborations, and licensing. Furthermore, Exicure may establish platform partnerships with pharmaceutical companies across manifold indications or within specific therapeutic areas.
The Company's proprietary 3-dimensional, Spherical Nucleic Acid (SNA™) architecture unlocks the potential of therapeutic oligonucleotides in a wide assortment of cells and tissues. SNA constructs overcome one of the most difficult obstacles to nucleic acid therapeutics - the safe and effective delivery into cells and tissues.
Exicure is using its SNA technology to mobilize the body's natural defense against cancer. Its lead immunotherapy compound, AST-008 (initially being investigated in selected solid and hematological tumors) is a toll-like receptor 9 agonist. The design of it is to use the SNA's beneficial properties to drive a strong anti-cancer immune response.
In December, Exicure announced top-line results from a Phase 1 clinical trial evaluating XCUR17 in patients with mild-to-moderate chronic plaque psoriasis. XCUR17 is an SNA drug targeted to mRNA encoding interleukin 17 receptor alpha, or IL-17RA. IL-17RA is a key protein that propagates inflammation. In preclinical studies, XCUR17 inhibited IL-17RA expression in human skin and in psoriatic mouse models.
Dr. David Giljohann, Chief Executive Officer, said, “We are pleased to announce the first clinical benefits of our SNA platform in patients. This is a milestone for our SNA platform and for our mission to create a new class of locally-applied, genetically-targeted drugs. Findings from this Phase 1 trial suggest that SNA-based drugs, such as XCUR17, may address clinical symptoms in patients with inflammatory diseases such as psoriasis.”
Exicure, Inc. (XCUR), closed Friday's trading session at $2.90, down 1.36%, on 28,925 volume with 63 trades. The average volume for the last 3 months is 27,074 and the stock's 52-week low/high is $2.78/$6.50.
EnviroLeach Technologies, Inc. (EVLLF)
Stock Market Revolution, Stockhouse, GuruFocus, 4-Traders, Dividend Investor, OTC Markets, Barchart, Investopedia, Marketwired, Streetwise Reports, MarketWatch, and Investors Hub reported earlier on EnviroLeach Technologies, Inc. (EVLLF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
EnviroLeach Technologies, Inc. is a technology business and near-term gold producer. It engages in the development and commercialization of environmentally-friendly formulas and technologies for the treatment of materials in the mining and E-Waste sectors. The Company’s aim is to become a leading gold producer via the “Urban-Mining” of end-of-life electronics and to be a major player in the extraction of precious metals in the traditional mining space. OTCQB-listed, EnviroLeach Technologies has its corporate office in Burnaby, British Columbia.
The EnviroLeach reagent is well suited for the leaching of gold in an agitated or vat leach type process. This includes the treatment of whole ores, gravity concentrates, flotation concentrates, and E-Waste. This segment of the market represents most of the worldwide gold produced.
Utilizing its proprietary non-cyanide, non-acid based process, EnviroLeach extracts precious and base metals from ores, concentrates, and E-Waste using only Food and Drug Administration (FDA) approved additives. The Company developed an inventive, cost-effective and environmentally-friendly alternative to cyanide and strong-acid based processes currently used for the extraction of precious metals from mineral ores, concentrates, and E-Waste.
The process is similar to the standard cyanide vat leaching circuits used today. However, it is much safer and simpler. The patent-pending EnviroLeach formula consists of combining five non-toxic, FDA approved dry ingredients with ambient temperature water.
EnviroLeach Technologies and Mineworx Technologies successfully advanced their proven chemical formulas and mechanical processes in 2017 with several additional proprietary and patent-pending breakthroughs. The new discoveries include significant enhancements to the proven EnviroLeach E-Waste process concerning improved leach kinetics, improved recoveries, metal complex stability, element selectivity, metal precipitation and the reusability of the main solution.
Furthermore, the two companies completed the design, engineering and construction of the initial production scale, 10 tonne per day E-Waste processing plant, which was installed on-schedule and on-budget at the Memphis, Tennessee facility.
Last month, EnviroLeach Technologies announced that the EnviroLeach Board of Directors approved the funding and start of Phase 2 of the Vancouver facility development. This phase includes the development of version 2.0 of chemical treatment plant. The expected completion date of Phase 2 is estimated for Q2 2019.
Mr. Duane Nelson, Chief Executive Officer, stated; “Following the successful launch of the dry concentrate line in our Vancouver facility, the next step is to develop our chemical treatment line. This exclusive process will allow us to maximize the recovery of precious metals from the organic/light fraction following concentration. This improved process is similar to the existing Memphis facility but will now run as a continuous process which reduces the size of the plant considerably, increases throughput, streamlines both the operation and efficiencies.”
Moreover, in December, EnviroLeach Technologies announced that it will receive a non-repayable contribution of up to $95,000 from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP). This is a federally funded program. It supports the research and development of innovative Canadian technologies, products or services. The funding will be used in the continued advancement of EnviroLeach Technologies’ proprietary chemistry and related technologies.
EnviroLeach Technologies, Inc. (EVLLF), closed Friday's trading session at $0.64183, down 4.94%, on 34,432 volume with 19 trades. The average volume for the last 3 months is 22,245 and the stock's 52-week low/high is $0.5474/$1.8554.
PetroShare Corp. (PRHR)
DreamTeamNetwork, Stockwatch, Stockhouse, InvestorsHub, SmallCapVoice, OilandGas360, Penny Stock Hub, Dividend Investor, Simply Wall St, The Street, Capital Cube, and 4-Traders reported earlier on PetroShare Corp. (PRHR), and today we report on the Company, here at the QualityStocks Daily Newsletter.
PetroShare Corp. is a domestic oil and natural gas exploration and development company headquartered in Englewood, Colorado. It targets capital deployment opportunities in established unconventional resource plays. The Company established to investigate, acquire, and develop oil and gas properties in the Rocky Mountain and mid-continent regions of the United States. PetroShare lists on the OTC Markets Group’s OTCQB.
PetroShare’s properties include Todd Creek Farms (Southern Wattenberg Field, NE Colorado; Niobrara and Codell Oil and Gas Development). The Company’s present focus is in the Niobrara/Codell formations and adjacent oil and gas producing zones in the Rocky Mountain region. Specific targets are in the Wattenberg field within the DJ Basin of northeast Colorado.
PetroShare is expanding its group of properties by way of organic drilling and development, in addition to strategic acquisitions and joint ventures (JVs). It acquired an initial acreage position of roughly 1,280 gross acres (333 net acres) in the heart of the oil dominated Niobrara/Codell resource development fairway in the southern end of the Greater Wattenberg Field region of NE Colorado.
The Company’s properties also include the Buck Peak Prospect (Sand Wash Basin, NW Colorado; Niobrara Oil Development). This Prospect is 7,700 gross acres (1,000 net acres) situated in Moffat County. PetroShare has drilled and completed two producing wells in this prospect. The Buck Peak Prospect targets oil and associated wet gas from the fractured Niobrara Shale formation. The Company’s Shook pad development program comprises 6 Codell wells and 8 Niobrara wells targeting all three Niobrara benches.
This past November, PetroShare provided its 2018 Q3 financial results. Production increased 23 percent to 112,564 BOE, or 1,224 BOE/day versus the corresponding year ago period. Revenues rose 84 percent to $5.2 million for the three months ended September 30, 2018 in comparison to the corresponding year ago period. Net Loss was $1.4 million, Operating Income was $1.3 million and Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) was $3.3 million for the three months ended September 30, 2018.
PetroShare Corp. (PRHR), closed Friday's trading session at $0.84, up 0.72%, on 650 volume with 1 trade. The average volume for the last 3 months is 9,472 and the stock's 52-week low/high is $0.30/$1.54.
Tempus Applied Solutions Holdings, Inc. (TMPS)
MarketWatch and InvestorsHub.com reported on Tempus Applied Solutions Holdings, Inc. (TMPS), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
OTCQB-listed, Tempus Applied Solutions Holdings, Inc. provides design, engineering, systems integration, and flight operations solutions. These support critical aviation mission requirements for a variety of customers. The Company maintains a highly qualified and skilled in-house engineering team, which supports aircraft modifications, certification, maintenance, as well as flight testing. Tempus Applied Solutions, LLC is the wholly-owned subsidiary of Tempus Applied Solutions Holdings, Inc. Tempus Applied Solutions has its headquarters in Williamsburg, Virginia.
The Company flies airplanes - fixed wing and rotary, manned or unmanned. It engages in surveillance missions in Africa to flight training in Texas. In addition, Tempus designs and modifies aircraft for special missions, certifies them, and provides turnkey lease and service solutions.
The Company operates Gulfstream, Bombardier, Pilatus, and Cessna aircraft. Most of these aircraft have been specially modified by Tempus for Department of Defense (DoD)-related missions. This includes threat simulation, surveillance, communications relay, and diverse test and development programs.
The Company’s Tempus Applied Solutions subsidiary was awarded FAA (Federal Aviation Administration) approval, in the form of a Supplemental Type Certificate (STC), for Tempus' initial FANS/1-A and ADS-B compliance solution [(Tempus' "Solution AA")]. Tempus' solution has received an "Approved Model List", or AML, STC, which means that it can be applied to any business and commercial aircraft. FANS and ADS-B compliance will be mandated in most parts of the world by 2020.
Tempus Applied Solutions uses a secure facility with hangar and manufacturing space and secure communications at Brunswick Executive Airport. The facility has two parallel 8000’ x 200’ runways and a 4.5-million-square-foot ramp and taxiways - certified for B-747, A-340, and C-5 aircraft.
The Tempus Design & Engineering Center of Excellence has Designated Engineering Representative (DER) authority from the Federal Aviation Administration (FAA) and the European Aviation Safety Agency (EASA). This center’s specialties include major airframe modifications; interior completions projects; design and materials specifications; modeling and rendering utilizing 3D Max Vision; Supplemental Type Certificates (STC); and Layout of Passenger Accommodations (LOPA) Development.
Recently, Tempus Applied Solutions announced that it was awarded a contract from the United States Air Force (USAF) to provide technical services and flight operations to the USAF Weapons Development and Integration Directorate, (WDID) Platform Integration Function, for aviation systems. Tempus Applied Solutions will integrate the USAF's High-Altitude LIDAR Atmospheric Sensing (HALAS) system into a modified Gulfstream IV aircraft owned by the Company.
This month, Tempus Applied Solutions announced that it entered into a definitive purchase agreement for the acquisition of six Lockheed L-1011s previously owned and operated by the Royal Air Force (RAF) of the United Kingdom (UK). Four of these aircraft are specifically configured for air-to-air refueling (AAR) operations. The remaining two are configured for passenger and cargo operations only.
These aircraft have numerous years of service life remaining. The L-1011s have been in flyable storage in the UK since their retirement. The closing of the acquisition will take place following satisfactory inspection of the aircraft and associated log books and support equipment.
Last week, Tempus Applied Solutions reported its first quarterly Operating Profit as part of its financial results for Q2 of 2017 (April 1 – June 30). The Company delivered more than $300,000, or $0.03 per share (average weighted number of shares), in Operating Profit in comparison to a $1.10 million Loss and negative $0.12 per share from the same period last year. It’s the first Operating Profit since the Initial Public Offering (IPO) in 2015.
Tempus Applied Solutions Holdings, Inc. (TMPS), closed Friday's trading session at $0.12, up 1.69%, on 23,700 volume with 9 trades. The average volume for the last 3 months is 7,383 and the stock's 52-week low/high is $0.031/$0.379.
Nanophase Technologies Corp. (NANX)
Schaeffer’s, StockEgg, Stealth Stocks, CoolPennyStocks, Wall Street Resources, SmarTrend Newsletters, Investment Contrarians, RedChip, Profit Confidential, BullRally, Stock Rich, HotOTC, and Penny Invest reported previously on Nanophase Technologies Corp. (NANX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Nanophase Technologies Corp. is a technology leader in nanomaterials and advanced nanoengineered products. The Company provides nanoengineered solutions for numerous industrial product applications. Nanophase assists its customers in succeeding, with proprietary and patent protected technologies. These technologies allow them to create unique products. OTCQB-listed, Nanophase Technologies is based in Romeoville, Illinois.
Nanophase delivers commercial quantity and quality nanoparticles, coated nanoparticles, and nanoparticle dispersions in a variety of media. The Company produces engineered nanomaterial products for use in an array of markets. These markets include Surface Finishing, Exterior Coatings, Personal Care, Plastics, Scratch Resistant Coatings, as well as Textiles.
Nanophase’s products include Aluminum Oxide, Antimony Tin Oxide, Bismuth Oxide, Cerium Oxide, Iron Oxide, and Zinc Oxide. Nano metal oxides provide UV protection across plastics, exterior coatings, and textile applications. Infrared absorbing particles create high clarity, energy saving films and interlayers.
The Company’s nano and submicron Aluminum Oxide imparts scratch resistance to coatings for wood, laminates, packaging, graphic arts, and electronics. Nano metal oxide technology improves the durability and capacity of zinc anode-based batteries.
Regarding nanoparticle surface treatment, Nanophase Technologies utilizes patented and proprietary particle coating technology to tailor the surface of the nanoparticles by discreetly encapsulating individual particles. The process can be used to impart a broad spectrum of functionality to the particles that, in addition to helping to ensure success in the application, provides the Company’s customers with a considerable deal of flexibility in formulation with the nanoparticles. Nanophase Technologies can provide the products in dry powder or pre-dispersed formats.
Concerning nanoparticle production technology, the traditional and most customary manufacturing methods used at the Company are plasma-based. The Physical Vapor Synthesis (PVS) and NanoArc® Synthesis (NAS) methods use transferred and non-transferred electric arcs to vaporize precursor materials. These are then carefully condensed to produce nanoparticles with desired properties.
Pertaining to Dispersion Technology, the Company has developed dispersed product formats for all of its nanocrystalline metal oxides. These concentrated dispersions are manufactured using an assortment of polar and non-polar organic solvents, water, as well as monomers as the continuous phase. The proprietary chemistry and process technology employed to prepare these dispersions ensures that Nanophase’s customers receive ready-to-use products in which the nanoparticles are stabilized at their primary particle size, with no secondary structure or agglomeration.
Nanophase Technologies Corp. (NANX), closed Friday's trading session at $0.73575, up 0.10%, on 1,155 volume with 2 trades. The average volume for the last 3 months is 6,609 and the stock's 52-week low/high is $0.40/$1.34.
CurAegis Technologies, Inc. (CRGS)
Penny Stock Tweets, Dividend Investor, Insider Mole, Equity Clock, Market Screener, Morningstar, MarketWatch, 4-Traders, InvestorsHub, Stockwatch, Investor Place, Simply Wall St, Marketbeat, Capital Cube, YCharts, Stock Invest, Barchart, The Street, OTC Markets, Infront Analytics, Stockhouse, last10k, Wallet Investor, and TradingView reported earlier on CurAegis Technologies, Inc. (CRGS), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Technologies, Inc. develops and markets advanced technologies in the areas of power, safety, and wellness. The Company consists of two independent divisions. One is its CURA Division and the other is its Aegis Division. CurAegis is now concentrating on commercialization strategies in diverse technologies. These include the CURA system, which includes the myCadian™ watch that measures degradation of alertness and sleep attributes; the Z-Coach e-learning education and training tool, and the Aegis hydraulic pump. OTCQB-listed, CurAegis Technologies is based in Rochester, New York.
The CURA™ system and the myCadian™ watch enable the user and third parties to anticipate and prevent undesired or disastrous situations caused by the degradation of alertness. CurAegis completed its validation studies of the CURA System at the University of Colorado at Boulder and the University of Rochester Medical Center. The Company previously said that it can now state that it can predict a person’s fatigue level, at close to laboratory accuracy, in real-time.
The CURA System consists of hardware and software, which measures numerous metrics to establish that a person's ability to perform a task or job appears to be degrading. The CURA division is developing a proprietary technology and family of products designed to measure the reduction in a person’s alertness and to train persons on how to improve alertness levels. The CURA System gives a person accurate and relevant real-time information regarding their current and long-term sleep and fatigue health.
The Company’s Aegis hydraulic pump (Aegis Division) is an innovative hydraulic design. Its goal is to deliver better efficiencies in a package that is smaller and lighter than contemporary technologies. Moreover, in 2015, the Z-Coach e-learning tool was acquired by CurAegis Technologies. The Z-Coach® Wellness Program is a robust, proven and proprietary online sleep training and education solution to address sleep issues and improve wellness.
In December, Mr. Richard A. Kaplan, Chief Executive Officer of CurAegis Technologies announced that Mr. Lance F. Drummond was appointed to the Company’s Board of Directors. At present, Mr. Drummond is a Board member of Federal Home Loan Mortgage Corporation (Freddie Mac). He has served on the Audit Committee and Nominations and Governance Committee since 2015. He is a Board member for United Community Bank, Inc. since 2018, where he serves on the Risk Committee, Nominating and Governance Committee and Compensation Committee.
CurAegis Technologies, Inc. (CRGS), closed Friday's trading session at $0.22, down 6.50%, on 1,616 volume with 1 trade. The average volume for the last 3 months is 24,256 and the stock's 52-week low/high is $0.10/$0.49.
The QualityStocks Company Corner
- Plus Products Inc. (CSE: PLUS) (OTC: PLSPF)
- Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)
- Spectrum Global Solutions, Inc. (SGSI)
- DPW Holdings, Inc. (NYSE American: DPW)
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)
- SinglePoint, Inc. (SING)
- Icon Exploration Inc. (TSX.V: IEX.H)
- Zenergy Brands, Inc. (ZNGY)
- Sunniva Inc. (CSE: SNN) (OTC: SNNVF)
- Net Element, Inc. (NASDAQ: NETE)
- Kontrol Energy Corp. (CSE: KNR) (FSE: 1K8)
- ChineseInvestors.com (CIIX)
- FinCanna Capital Corp. (CSE: CALI) (OTC: FNNZF)
- BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT)
Plus Products Inc. (CSE: PLUS) (OTC: PLSPF)
Leading California edibles manufacturer Plus Products (CSE: PLUS) recently reported the completion of the acquisition of GOOD CO-OP Inc., a California-based cannabis-infused baked goods brand. A recent article discussing the company reads, “This acquisition is expected to enable Plus to solidify its top position in the edibles field (http://nnw.fm/572iG). To view the full article, visit: http://nnw.fm/7Jo0w.
Plus Products Inc. (CSE: PLUS) (OTC: PLSPF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.
First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.
PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.
Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.
During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:
- Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
- Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
- Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
- Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
- Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
- Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.
“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”
The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.
Plus Products Inc. (PLUS), closed the day's trading session at $4.65, up 8.90%, on 21,663 volume with 42 trades. The average volume for the last 3 months is 104,891 and the stock's 52-week low/high is $2.81/$4.25.
- NetworkNewsBreaks – Plus Products Inc. (CSE: PLUS) Reinforces its Position in the California Edibles Space through Acquisition
- 420 with CNW – Rhode Island Considers Using Medical Cannabis to Stop Opioid Dependency
- Plus Products Inc. (CSE: PLUS) Solidifies Leading Edibles Position in California with Acquisition of Cannabis-Infused Baked Goods Manufacturer
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)
A biotech company, Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) offers a unique platform that makes it possible to deliver bioactive substances through oral ingestion. Its DehydraTECH technology accomplishes this without the need for unhealthy inhalational dosing. DehydraTECH uses only GRAS (Generally Recognized as Safe) ingredients and increases bio-absorption by five to 10 times. Based in Kelowna, British Columbia, Lexaria Bioscience is the only company globally with patents issued for the oral delivery of all cannabinoids.
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.
The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.
In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.
Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.
Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.
Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.
Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.27, up 8.55%, on 72,402 volume with 105 trades. The average volume for the last 3 months is 178,210 and the stock's 52-week low/high is $0.75/$2.43.
- Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) CEO Discusses Company Initiatives at O’Cannabiz 2018
- Exclusive Interview: Lexaria CEO Discusses Progress & Plans at O’Cannabiz 2018 -- CFN Media
- NetworkNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Proprietary Technology Transforms the Way Molecules Enter the Body
Spectrum Global Solutions, Inc. (SGSI)
Leading telecommunications engineering and infrastructure services provider Spectrum Global Solutions (OTC: SGSI) recently announced that it has acquired Telnet Solutions, Inc. (“TNS”). TNS is a Des Plaines, Illinois based company that offers design, installation and maintenance of structured cabling system solutions to the enterprise market in the US and abroad. To view the full press release, visit: http://nnw.fm/S91Kl.
Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:
- AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
- ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
- Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.
Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.
Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.
CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.
Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.
Spectrum Global Solutions, Inc. (SGSI), closed the day's trading session at $0.1745, up 45.42%, on 76,832 volume with 33 trades. The average volume for the last 3 months is 21,737 and the stock's 52-week low/high is $0.10/$2.59.
- NetworkNewsBreaks – Spectrum Global Solutions, Inc. (SGSI) Acquires Telnet Solutions, Inc.
- Spectrum Global Solutions, Inc. (SGSI) Displays Capability to be One Stop Shop for 5G
- Spectrum Global Solutions, Inc. (SGSI) Offers Total Telecom Services via its Varied Subsidiaries
DPW Holdings, Inc. (NYSE American: DPW)
DPW Holdings, Inc. (NYSE American: DPW) a diversified holding company (the “Company”) announced today that it has completed establishing DPW Financial Group, Inc. and DPW Technologies Group, Inc., both Delaware corporations, as previously announced on November 6, 2018. DPW anticipates aggregating all reporting by its subsidiaries and business units through these two new subsidiaries, starting as early as the first quarter of 2019. This realignment will set the stage for other initiatives by the Company in 2019 and beyond.
DPW Holdings, Inc. (NYSE American: DPW), is a diverse holding company pursuing a growth strategy of acquiring undervalued assets with disruptive technologies with a global impact.
The company invests in diverse industries within the commercial, defense/aerospace, industrial, communication, medical, crypto-mining, hospitality, textile, and corporate investment/lending sectors. DPW has evolved and grown from being a leader in advanced power products. Through its subsidiaries, the company continues to be a leader and supplier of innovative technologies, advanced design and development services, and state-of-the-art power products and solutions.
Through its wholly owned Coolisys Technologies, Inc. subsidiary, DPW is committed to offering world-class technology-based solutions for critical applications and lifesaving services that are primarily driven by innovation. Coolisys targets to the defense, aerospace, naval, homeland security, medical, telecom, datacom and industrial markets. Its growth strategy centers on core markets that are characterized by “high barriers to entry” and require specialized products and services not likely to be commoditized. Through a portfolio of companies, Coolisys is engaged in developing and manufacturing advanced switching power products and power solutions that utilize a customized digital power management and resonant topology to attain:
- The highest efficiency and highest density power converters and inverters
- Specialized complex airborne high-frequency, radio frequency (RF), and microwave detector-log video amplifiers (DLVA)
- Very high-frequency filters
- Naval power conversion and distribution equipment
Coolisys offers its technology and services through three primary groups: the Power Solutions Group (PSG), the Defense and Aerospace Solutions Group (DSG), and the Advanced Service Industries (ASI) Group. Coolisys manages five divisions:
- Digital Power Corporation, a leader in providing power electronics technology that is based in northern California.
- Digital Power Limited dba Gresham Power Ltd, a designer and manufacturer of power distribution systems primarily for Naval use that is based in Salisbury, UK.
- Microphase Corporation, a designer and manufacturer of microwave electronics technology that is based in Shelton, Connecticut.
- Power-Plus Technical Distributors, a value-added distributor that is based in Sonora, California.
- Enertec Systems, a developer and manufacturer of specialized advanced electronic systems for the defense and aerospace sectors that is based in Karmiel, Israel.
DPW’s portfolio of wholly owned subsidiaries also includes Digital Power Lending, LLC (DPL), a California private lending company operating under Financial Lender’s License ##60DBO-77905. DPL is dedicated to strategically providing capital to small and middle-size businesses for an equity interest in addition to loan fees and interest. DPL provides secured and unsecured debt financing for public and private companies. These loans will typically have a six to 12-month maturity and range from $250,000-$5 million. DPL is active in bridge loans, receivable financing, inter company loans and micro loans. DPL will work with a network of company owned ATMs (terminals) in California, which will help utilize its CA Finance Lending License and enable the company to offer micro loans of up to $500 or less.
Management has over 50 years of Wall Street experience of investing in, and building companies. DPL’s desire is to bring world-class companies lending opportunities while allowing main street investors to participate. Deal flow and organization comes from an extensive network of investment bankers, business brokers, family offices, and institutional clients enabling DPL to engage and fund the most compelling companies from Silicon Valley to Wall Street.
To date, DPL has funded over $19 million in loans. Since inception, DPL has internally funded over $15 million to DPW’s portfolio companies and wholly owned subsidiaries. As for companies outside DPW, DPL has lent over $4 million in commercial and real estate loans. DPL has funded INVO Bioscience, Medovex, Parallax, Alzamend Neuro, as well as hospitality clients, such as Guilia DTLA and Prep Kitchens.
Another subsidiary wholly owned by DPW is Super Crypto Mining, Inc., a cloud computing service that provides shared and managed computing resources optimized for various block chain mining solutions. Based in Newport Beach, California, Super Crypto Mining leverages its engineering expertise and existing locations to create cryptocurrency mining facilities throughout the world. The company owns and maintains the computing resources and sells access to their use. The established mining is on the Top 3 crypto-currencies with the goal of having 10,000 miners deployed in 2018. Super Crypto Mining endeavors to leverage its engineering expertise and existing global facilities (high-security defense business locations) to secure mining farms. Super Crypto Mining is a rapidly growing organization that recently strategically secured 25 mega watts to power the company’s mining farm. For crypto currency mining, locations with inexpensive power and secure capacity are minimal and hence costly. Having such a location allows the company to grow its mining business to more than 20,000 mining machines. Super Crypto Mining continues to purchase mining machines and explore opportunities to expand its services into other related areas including mining farm real estate investments, mining machine development, and mainstream blockchain projects.
DPW additionally has beneficiary ownership in MTIX International, Inc., the parent company of MTIX, Ltd. and I.AM, Inc.
MTIX was acquired by Avalanche International aka MTIX International, Inc., in August 2017 and offers “green technology” that uses a proprietary laser process to enhance the surface of textiles. This process reduces water usage by approximately 75 percent, reduces greenhouse gases by approximately 90 percent, and reduces chemical use by approximately 95 percent.
I.AM, acquired in May 2018, owns and operates hospitality offerings that include four Prep Kitchen brand restaurants and Giulia DTLA.
Utilizing a shareholder-centric approach to compensation, DPW has formulated the following 10-year objectives:
- Achieve compounded annual revenue growth of 25-35%
- Achieve compounded annual net Income growth of 5%
- Achieve positive unrestricted free cash flow by the end of 2019
DPW is led by a seasoned team of successful business professionals and entrepreneurs. The company is headquartered in Newport Beach, California.
DPW Holdings, Inc. (DPW), closed the day's trading session at $0.123206, up 11.00%, on 6,919,802 volume with 6,024 trades. The average volume for the last 3 months is 1,789,466 and the stock's 52-week low/high is $0.09/$3.14.
- DPW Holdings, Inc. Reports Progress on Corporate Realignment
- NetworkNewsBreaks – DPW Holdings, Inc. (NYSE American: DPW) Subsidiaries Receive Debt Financing to Decrease Defense Sector Order Backlog
- DPW Holdings Authorizes Pursuit of Initial Public Offering for its DPW Technology Group
Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)
NetworkNewsAudio announces the Audio Press Release (APR) titled “Global EV Demand Drives Scramble for Fresh Supplies of Vital Metals,” featuring Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE). To hear the NetworkNewsAudio version, visit: http://nnw.fm/Ny6fh. To read the full editorial, visit: http://nnw.fm/2liAM.
Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is a Canada-based exploration company focused on the acquisition and development of production-grade cobalt deposits, a key raw material input for the growing lithium-ion battery industry.
Pacific Rim Cobalt and its Cyclops Nickel-Cobalt Project, located in the Depapre District, Jayapura Regency, Papua Province, Republic of Indonesia, is uniquely positioned in a region with potentially the largest source of cobalt outside of Africa. Strategically located near China, the world’s largest cobalt buyer, the Cyclops Project is a laterite (iron-hosted) mineral prospect, rich in cobalt and nickel. Cobalt consumption in China is on-track to use over 8,000 tonnes of cobalt annually by 2021 for electric vehicle production alone and is projected to remain the world’s largest cobalt consumer for many years to come.
Global demand for renewable power is fueling a massive shift from traditional energy supply chain economics to cobalt-reliant lithium-ion batteries, the world’s most widely used power source for portable applications such as electric vehicles and other high-tech applications.
Pacific Rim Cobalt management has concluded that strategic access to major markets offers the most important factor to servicing the rising demand for cobalt. The company’s acquisition of its initial asset in Indonesia offers near surface, strong nickel-cobalt mineralization in an area with excellent infrastructure including a nearby workforce, supplies, sealed roads, ocean access, nearby port facility and gentle topography. The project area, nestled on the north coast of Papua, Indonesia, establishes Pacific Rim Cobalt well within the economically attractive ocean-going transportation range to Asia and its lucrative, growing industrial markets.
Exploration efforts are currently focused on establishing a maiden compliant resource for the Cyclops project, both in historically identified and drill-tested prospects as well as previously unexplored areas of the claims. During the first nine months of 2018, the company focused on assembling the necessary agreements to access northern areas of the project hosting historically identified mineralized zones. Mapping, sampling and a mini-bulk sample within the mineralized zones has been completed, along with a small-scale program in the previously unexplored far southern area of the project. With surface access to priority targets now established, Pacific Rim Cobalt will initiate drilling and extract additional mini-bulk samples for further metallurgical testing.
“We are excited and optimistic about the unique possibility of developing this project into an asset that will add shareholder value and position the company to play a future role in the battery metals supply chain,” Pacific Rim Cobalt CEO Ranjeet Sundher recently stated (http://nnw.fm/u1HNs). “We expect the near-surface nature of cobalt/nickel mineralization at the Cyclops project will lend itself well to low-cost, logistically straightforward drilling. We thus anticipate the opportunity to undertake a resource calculation study, as well as ongoing metallurgy and process option testing, will present itself in the near future. It’s going to be a busy year ahead, and we look forward to getting the drills turning and building value.”
Pacific Rim Cobalt’s world-class management team includes Sundher, who has over 20 years of capital markets experience. Sundher is also president of Canrim Ventures Ltd., a Singaporean advisory firm specializing in early stage project finance and structure. He previously founded Indogold Exploration, a Jakarta-based mining service firm, and has raised over $40 million for companies in which he was a founder/partner.
Chief Financial Officer Steve Vanry has 25 years of professional experience in senior management positions with public and private natural resources companies, providing expertise in capital markets corporate finance, mergers and acquisitions, regulatory compliance, accounting and financial reporting.
Andre Talaska serves as country manager and technical supervisor. He has over 30 years of experience in the mining and exploration industry and has held senior positions with several companies in Australia and southeast Asia. Shakir Juffry, business development/engineering, is a chemical engineer and extractive metallurgist by background training who has over 20 years of experience in the Indonesian mining and minerals exploration field. Toto Suarto Sajali, operation and development manager, is a mining engineer with over 15 years of experience in Indonesian project assessment, development and operations.
Pacific Rim Cobalt Corp. (OTCQB: PCRCF), closed the day's trading session at $0.1306, up 5.01%, on 25,428 volume with 10 trades. The average volume for the last 3 months is 17,587 and the stock's 52-week low/high is $0.0701/$1.118.
- NetworkNewsAudio Announces Audio Press Release (APR) on Pacific Rim Cobalt Corp. Well Positioned in Hunt for Cobalt
- NetworkNewsWire Announces Publication on Multinational Companies and Industrialized Nations Working to Secure Critical Metals
- Global EV Demand Drives Scramble for Fresh Supplies of Vital Metals
SinglePoint, Inc. (SING)
SinglePoint, Inc. (OTCQB: SING), a fully reporting technology company providing mobile payments, blockchain solutions and ancillary cannabis services, is quickly taking advantage of its first-mover status in the CBD space with an investment in TorusMed Inc., which plans to develop CBD cell cultures from industrial hemp with photobioreactors. In a news release announcing the investment, SinglePoint said that the project’s goal is to ultimately have pharmaceutical grade CBD cultivated in a lab setting to ensure consistency of a premium product (http://nnw.fm/Gt876). Also today, SinglePoint was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally-syndicated program reviews money-focused topics, featuring in-depth CEO and executive interviews from various companies offering insights into their operations and future outlooks. To view the full press release, visit: http://nnw.fm/qDL51.
SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.
SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.
SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:
- A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
- A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
- A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
- Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
- Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
- Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.
SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.
Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.
SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.
SinglePoint, Inc. (SING), closed the day's trading session at $0.02, even for the day, on 3,513,700 volume with 240 trades. The average volume for the last 3 months is 6,303,560 and the stock's 52-week low/high is $0.01/$0.096.
- SinglePoint, Inc. (SING) Eyes Unique Production of CBD Cell Cultures with Investment in TorusMed Inc.
- NetworkNewsBreaks – SinglePoint, Inc. (SING) CEO Discusses CBD Legalization’s Impact to Business on MoneyTV with Donald Baillargeon
- SinglePoint Looks Ahead to 2019 Highlighting Company Direction and Acquisitions
Icon Exploration Inc. (TSX.V: IEX.H)
As investors and consumers alike assess the gains and losses evident during the “green rush” of 2018, when companies such as Icon Exploration Inc. (TSX.V: IEX.H) launched aggressive efforts to capitalize on changing laws and attitudes regarding cannabis, their attention is turning toward companies that can deliver revenues by ensuring a steady product pipeline (http://nnw.fm/f4YlB). Icon Exploration’s efforts to create a well-diversified company focused on becoming a leading purveyor of medicinal and recreational cannabis is evidence that the company’s industry-experienced team is preparing to meet that demand. Also today, the company was featured in a NetworkNewsBreak looking at how Icon Exploration is diligently working toward establishing its foothold in the global cannabis sector. To view the full article, visit: http://nnw.fm/Avv0F.
Icon Exploration Inc.'s (TSX.V: IEX.H) primary objective is to create a well-diversified company focused on assessing and potentially acquiring targets in the cannabis industry. Icon Exploration recently signed a formal share exchange agreement relating to its proposed acquisition of privately held City View Green (“CVG”), a vertically integrated cannabis company incorporated under the laws of Ontario, Canada. CVG’s application to Health Canada for an Access to Cannabis for Medical Purposes Regulations (“ACMPR”) license is now at the in-depth review stage of the licensing process.
CVG is preparing a 40,000-square-foot growing facility near Toronto to produce pharmaceutical-grade cannabis once its ACMPR license is granted. About half of the facility will initially be outfitted with state-of-the-art LED lighting, HVAC and dehumidification systems, and automation technologies to optimize the quality, safety and consistency of cannabis production. About 4,000 square feet will be devoted to an extraction laboratory featuring an ultra-efficient CO2 supercritical extraction process with plans to include ethanol extraction technology in the future.
Another 4.3 acres remains available for future construction of up to 125,000 square feet of grow and extraction space. Production plans include producing high quality edible products, distillates, and water-soluble products for the rapidly expanding CBD-infused (cannabidiol) beverage market.
Icon and CVG have assembled a talented team that includes a Master Grower with cannabis-industry experience to manage indoor grow operations and an extraction expert whose expertise in developing and launching new products was honed while working in Washington state’s cannabis sector. Having gained experience in the Washington state market the extraction expert has a number of brand ideas and recreational cannabis products that became popular in the Washington market as well as a number of in-licensing branding opportunities available to CVG. CVG has also negotiated an agreement with a private company seeking 37 retail cannabis licenses in Alberta, Canada, that provides a reciprocal exchange of shares, product, shelf space and distribution lines. Early discussions with various entities in Europe to arrange an off-take agreement for CBD oils and extracts are also underway.
The Canadian medical cannabis market has steadily been growing with an average 10 percent increase in patients each month. Now that the Canadian federal government has legalized recreational cannabis for adult users nationwide, analysts project a compound annual growth rate of nearly 78 percent from 2018 to 2021, reaching an estimated $3 billion by 2021, ArcView Market Research reports. One study from Deloitte pegged the potential economic impact of legalized medical and recreational marijuana in Canada – including transportation, licensing fees and security – at more than $22 billion over the coming years. Health Canada’s most recent data show that sales of cannabis extracts grew 961 percent in the second quarter of 2017, compared to an 89 percent increase in growth of dried cannabis during the same period.
Icon Exploration Inc. (TSX.V: IEX.H), closed the day's trading session at $0.41, even for the day. The stock's 52-week low/high is $0.335/$0.84.
- Icon Exploration Inc. (TSX.V: IEX.H) Builds Cannabis Product Pipeline While Awaiting ACMPR Approval
- NetworkNewsBreaks – Icon Exploration Inc. (TSX.V: IEX.H) Carving Out its Spot in the Cannabis Space
- Icon Exploration Inc. (TSX.V: IEX.H) Building Presence in Booming Cannabis Space
Zenergy Brands, Inc. (ZNGY)
Zenergy Brands (OTC: ZNGY), a leading next-generation energy and technology company, has secured a strong position for itself in a growing industry as the demand for energy-efficient technology is on the rise. To view the full article, visit: http://nnw.fm/3xtLH.
Zenergy Brands, Inc. (ZNGY) is the nation’s leading next-generation energy and technology company operating in the emerging smart energy, conservation, and utility industries. Headquartered in Texas, Zenergy provides an entire suite of conservation-based products and services that enable clients to achieve sustainability goals, reduce carbon emissions and improve their bottom line. The company’s cutting-edge Zero Cost Program™ reduces utility expenses by 20 percent to 60 percent by offering energy conservation, smart controls, and efficiency-based products and services to residential, commercial, industrial and municipal end-use customers.
The Zero Cost Program™ is a financing mechanism that allows customers to reduce water, natural gas and electricity expenses by implementing proven conservation technologies at no out-of-pocket cost. The Zero Cost Program™ enriches businesses by immediately reducing energy consumption through the use of smart controls, building automation, LED lighting solutions, refrigeration optimization, efficient water systems, EC motor controls, demand-side management and load factor correction.
A unique Managed Energy Services Agreement (“MESA”) allows a portion of these utility savings to be retained by Zenergy’s partner financing the upgraded, retrofit equipment and installation costs until a specified repayment period ends. After that, clients reap all the financial rewards of the technologies implemented, which Zenergy estimates should range between 25 percent and 45 percent of total utility costs.
Residential customers seeking cost-effective energy savings can also choose from a suite of “Smart Home” products including home automation, security monitoring, and energy conservation services that can be controlled 24/7 from the comfort and convenience of their smartphones or internet-connected smart devices. Zenergy’s residential program offers partnership opportunities for homebuilders and residential, multi-family real estate developers to provide smart home technologies to high-end customers.
Zenergy Brands’ acquisition of Enertrade Electric LLC, a fully operating, licensed Texas-based Retail Electric Provider (REP), further increases the company’s value proposition. Zenergy CEO Alex Rodriguez said this new subsidiary adds an essential complementary service to the company’s suite of smart energy products and services.
“Since our founding, our vision has been to converge smart controls (home and building automation) with energy conservation and retail energy to deliver the comprehensive smart energy service to customers,” Rodriguez said.
On a global scale, residential and commercial buildings account for nearly 45 percent of the world’s total energy consumption. Improving the energy efficiency of these homes and buildings is often a more affordable way to reduce harmful gas emissions while minimizing the need for new energy production. According to Navigant Research, global revenue for energy-efficient commercial building retrofits alone is expected to grow from $71.4 billion in 2016 to $100.8 billion in 2025. At the same time, the energy-efficient devices market is expected to reach a market size of $908 billion by 2022. Increasing demands for reduction in energy consumption and greenhouse gas emissions along with concerns over climate change are contributing factors driving the market’s overall growth.
Zenergy Brands, Inc. (ZNGY), closed the day's trading session at $0.0002, even for the day, on 326,260,691 volume with 102 trades. The average volume for the last 3 months is 68,503,446 and the stock's 52-week low/high is $0.000009/$0.013.
- NetworkNewsBreaks – Zenergy Brands, Inc. (ZNGY) Establishes Strong Position in the Energy Technology Sector
- Zenergy Brands, Inc. (ZNGY) Builds Consumers’ Capacity to Efficiently Manage Utilities Use While Conserving the Environment
- Zenergy Brands, Inc. (ZNGY) Offers Customers the Ability to Retrofit Outdated Energy Options with Intuitive Products and Services
Sunniva, Inc. (CSE: SNN) (OTC: SNNVF)
Sunniva Inc. (CSE: SNN) (OTCQB: SNNVF) was featured today in a report by CannabisNewsWire. Did you, in your wildest dreams, ever imagine that the start of your business venture would depend on the outcome of a lottery? Well, that is exactly the fate awaiting cannabis retail license applicants in Ontario, Canada. The provincial government led by the Progressive Conservatives has decided to use a lottery to select the first 25 private entities that will be allowed to open marijuana retail businesses.
Sunniva, Inc. (CSE: SNN) (OTC: SNNVF) is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – committed to delivering safe, consistent, high-quality products and services. Sunniva operates through its wholly owned subsidiaries: Sunniva Medical Inc., CP Logistics, LLC, Natural Health Service Ltd., and Full-Scale Distributors, LLC. Sunniva’s vision is to become the lowest cost, highest quality cannabis producer in the markets it serves by building large scale purpose-built cGMP-compliant greenhouses, offering best quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education, and sourcing better therapeutic delivery devices.
The company is establishing sophisticated distribution channels, including Sunniva’s ownership of Natural Health Services cannabis clinics in Canada with over 95,000 active patients, to purchase the significant quantities of high quality Sunniva-branded and Sunniva private-labeled cannabis products.
Sunniva is an ancient English name which means, “Gift of the Sun.” Sunniva’s team of horticulturists, scientists and engineers is helping to set best practices for the industry, believing that sun-grown, solar-powered cultivation is the most sustainable and cost-effective way to grow high-quality, premium cannabis.
The Sunniva Family includes:
CP Logistics, LLC
Through its subsidiary, CP Logistics LLC, Sunniva is developing Sunniva Campus, a state-of-the-art, purpose-built greenhouse facility in Cathedral City, California. This modern purpose-built, agri-technology greenhouse will adhere to the Current Good Manufacturing Practice (cGMP) regulations that assure proper design, monitoring and control of manufacturing processes and facilities.
Phase 1 of the project includes a fully funded 325,000 square foot greenhouse capable of producing 60,000 kg per year of dry cannabis at capacity with operations commencing Q3 2018. Approximately 30 percent of initial total production will be converted into oils and extracts. Phase 2 is expected to increase the greenhouse by 165,000 square feet and grow production by about 40,000 kg per year.
These uniquely sealed greenhouses are designed to deploy custom, automation assembly line cultivation processes at a large scale. Energy consumption will be reduced while utilizing the energy of the sun and microclimatic controls to provide precise growing conditions. The greenhouse will recirculate air for more efficient climate control, and the company’s Integrated Pest Management System is designed to ensure every plant grown is certified clean and free of all contaminants and pesticides.
Sunniva Medical Inc.
Sunniva Medical Inc. is designing and preparing to break ground on the Sunniva Canada Campus encompassing 700,000 square feet of purpose-built cGMP greenhouse facilities in the Okanagan Valley, British Columbia. The total campus is expected to produce 100,000 kg of premium medical cannabis a year plus additional trim used for extraction. This facility will produce pesticide-free products and will convert trim to extracted products such as cannabis oil that can be used for drug delivery formats such as capsules, dissolvable strips, vaporization cartridges, tinctures and creams.
Sunniva and Canopy Growth Corporation (“Canopy Growth”) recently announced a large take or pay supply agreement. Under the terms of the agreement, Canopy Growth will purchase up to 45,000 kilograms of dried cannabis annually commencing Q1 2019, which includes the distribution of Sunniva branded products. Sunniva Medical is a late-stage applicant under Canada’s ACMPR and is in the final review stage of the process.
Natural Health Services Ltd.
Natural Health Services (“NHS”) owns and operates a network of eight medical clinics in Canada specializing in medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). NHS connects licensed producers to their 21 physicians and patients with its proprietary SPARK software which utilizes a software-as-a-service revenue model. To date, there are 27 integrated licensed producers utilizing the SPARK software.
In-house physicians specializing in the endocannabinoid system provide expert consultation, education and recommendations for targeted phytoceutical remedies and wellness plans to improve the quality of life for all patients. NHS enjoys a long-term relationship with patients due to the quality of its physician-patient experience. A rapidly expanding NHS cannabis clinic network serves 94,000 active patients in Canada. NHS has also initiated a pilot program with a national pharmacy chain to aggregate more patients.
Full-Scale Distributors, LLC
Full-Scale Distributors, LLC is an industry leading provider of custom, private-label vaporizers through its brand, Vapor Connoisseur. The company currently serves the needs of over 80 top brands in the North American marketplace. Vapor Connoisseur is recognized for its high quality and innovative therapeutic delivery devices. Products are tailored to client needs, ensuring both safety and reliability.
Sunniva’s highly experienced management team is building partnerships with leading scientists, universities and clinical trial groups to deliver proprietary cannabis formulations to a broad spectrum of health ailments and conditions. These global partners require cGMP-certified facilities for the processing and manufacturing of cannabis products. Sunniva is committed to providing safe, pesticide-free, high quality, reproducible cannabis medicines.
Leading Sunniva is co-founder, chairman and CEO Dr. Anthony (Tony) Holler. He is the former CEO and founder of ID Biomedical, which was acquired in 2005 for $1.7 billion by GlaxoSmithKline. He is also the former chairman of Corriente Resources Inc., which was sold for approximately $700 million to CRCC-Tongguan Investment Co. Holler is currently chairman of CRH Medical Corporation, a public company trading on the TSX and NYSE. His expertise includes strategic planning, mergers and acquisitions and financing with a singular focus on increasing shareholder value.
Holler is joined by co-founder Leith Pedersen, who serves as president of Sunniva. Pedersen is the former owner and CEO of Vida Wealth Management Bahamas and was a former investment advisor at Canaccord Wealth Management. He is a former partner and director at JF Mackie and Company, an independent brokerage firm in Calgary, Alberta, that managed capital in excess of $2 billion for high net worth clients. Pedersen’s expertise is in corporate strategy, financing and mergers and acquisitions.
Sunniva, Inc. (SNNVF), closed the day's trading session at $3.62, off by 1.39%, on 52,259 volume with 101 trades. The average volume for the last 3 months is 104,917 and the stock's 52-week low/high is $2.035/$16.00.
- 420 with CNW – Ontario to Select Cannabis Retailers Using a Lottery
- NetworkNewsBreaks – Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Secures Over $2.4M in Initial Cannabis Product Sales in California
- Venture Breakfast Bits, by 24/7 Market News
Net Element (NASDAQ: NETE)
Net Element (NASDAQ: NETE), a global technology and value-added solutions group, serves businesses and consumers through its support of electronic payments in an omni-channel environment. To view the full article, visit: http://nnw.fm/Ho92g.
Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.
Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.
With an eye on emerging markets, Net Element is pursuing growth opportunities and footholds in a number of industries. The company’s most recent application of its technology is to the cannabis industry, which is paced to hit $591 million and could increase 40 times in the next four years. This rampant growth also creates heightened need for smooth transactions between merchants and consumers. Payment processing and compliance for the cannabis industry has become increasingly complex, and Net Element’s Unified Payments subsidiary is addressing the challenges by offering a compliant, seamlessly integrated payment solution that makes it simple to transact.
Net Element has also launched a blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.
“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”
Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.
Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:
- Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
- Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
- Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
- Payonline – A fully integrated, processor agnostic electronic commerce platform.
Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.
“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”
Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.
Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.
From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.
Net Element (NETE), closed the day's trading session at $6.29, off by 1.26%, on 87,475 volume with 277 trades. The average volume for the last 3 months is 317,586 and the stock's 52-week low/high is $3.75/$14.38.
- NetworkNewsBreaks – Net Element, Inc. (NASDAQ: NETE) Sees Promising Growth in North American Market
- Asset Acquisitions Grant New Potential to Payment Technology Developer Net Element, Inc. (NASDAQ: NETE)
- Net Element Launches Multi-Channel Blockchain-Powered Payments Acceptance Application as Part of its Netevia Platform
Kontrol Energy Corp. (CSE: KNR) (FSE: 1K8)
Kontrol Energy Corp. (CSE: KNR, FSE: 1K8), ("Kontrol" or the "Company") a leader in energy efficiency technology and solutions industry, is pleased to announce that it has submitted an application to have its common shares trading on the OTCQB Venture Market (the "OTCQB"). The listing of the Company's common shares on the OTCQB remains subject to the approval of the OTCQB and the satisfaction of applicable listing requirements.
Kontrol Energy Corp. (CSE: KNR) (FSE: 1K8) specializes in the integration of smart energy technologies and solutions for North American commercial and industrial property owners and operators to help them benefit from energy cost savings and minimize greenhouse gas emissions. Kontrol is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology and is ranked by Canadian Business and Maclean’s as the 7th fastest growing startup in 2018.
Kontrol’s leadership position is reshaping the way customers use, manage and strategically allocate energy resources to realize immediate energy savings by gaining more control over energy consumption and demand in real-time.
As the fastest growing global “fuel source,” energy efficiency is big business with industry analysts noting this multi-trillion-dollar market offers significant opportunities over the next five years. Established market segments include: energy retrofits ($71.4 billion); distributed generation ($179.9 billion); energy analytics ($33.5 billion); and greenhouse gas/carbon measurement, reduction ($1.2 trillion). Each $1 invested in energy efficiency displaces up to $3 of utility-scale transmission and distribution investment, according to the International Energy Agency.
Formed in 2015 by a group of energy veterans who recognized that the energy efficiency industry is one of the fastest growing fuel sources for the global economy, Kontrol is committed to enhancing and improving its customers sustainability objectives. In less than two years, Kontrol has grown its revenue run rate to $16 million from $1.8 million, delivering on stated goals and objectives as it seeks to continue this pattern through accretive acquisitions and the expansion of the company’s smart energy technologies.
Up to 50 percent of Kontrol’s overall revenues are recurring annually, and the company’s 2019 outlook includes strategic initiatives that will expand the company’s smart energy technologies to U.S. markets, bring additional accretive and strategic acquisitions, and accelerate recurring SaaS revenues.
Kontrol’s strategy of disciplined mergers and acquisitions includes the following highlights:
- Acquisition of Log-One Ltd.’s award-winning energy conservation technology, Energy Management System (“EMS”), an intelligent, occupancy-based heating and air-conditioning control system for commercial and multi-residential real estate. Rebranded as Kontrol EMS Technology, the company has added IoT and mobile application capabilities, creating a recurring revenue platform through a Software-as-a-Service (SaaS) platform.
- Acquisition of ORTECH Consulting Inc., an engineering consulting firm specializing in Greenhouse Gas (GHG) reporting, emission testing, air quality testing and renewable energy/power consulting.
- Acquisition of Efficiency Engineering Inc. (“EE Inc.”), which provides engineering services to industrial, municipal and commercial building owners across Canada. EE Inc. provides detailed energy efficiency analysis, energy audits, management of facility system solutions, electrical and mechanical design and energy conservation studies.
- Acquisition of MCW Dimax Ltd. (“MCX”), a firm specializing in solutions for the application of energy software to analyze the management of complex heating, ventilation and cooling systems for large residential, commercial, and mission critical real estate owners.
- Acquisition of CEM Specialties Inc. (“CEMSI”), a market leader in turn-key emission monitoring, equipment and solutions.
The company has also established entry into the North American cannabis market as a supplier of integrated energy efficiency solutions and technologies. Within this market, Kontrol is focused on assisting cannabis growers to reduce the cost of energy and support mission critical infrastructures. To date, Kontrol has secured two contracts to provide energy efficiency services with Licensed Producers in the Canadian cannabis sector.
The Kontrol Energy group of companies is currently saving its customers more than 40 million kilowatt hours of electricity per annum and providing a corresponding reduction in GHG emissions.
Kontrol’s management team includes CEO Paul Ghezzi, a leader in clean tech, renewable energy development, solar project financing and distributed generation. Ghezzi has global experience in power generation projects under Feed-in Tariff programs and Power Purchase Agreement programs for both commercial and utility-scale projects. COO Kristian Lavereau has more than 25 years of experience in the IT solutions (analytics and mobile computing), energy optimization and efficiency (intelligent control systems, solar PV, lighting). Claudio Del Vasto, CPA, CA | CFO, is a senior finance executive with an extensive background in corporate finance, strategy and business development.
Kontrol Energy Corp. (CSE: KNR), closed the day's trading session at $0.65, off by 1.52%, on 2,500 volume with 2 trades. The average volume for the last 3 months is 20,683 and the stock's 52-week low/high is $0.46/$1.58.
- Kontrol Energy Announces Application for OTCQB Listing
- Kontrol Energy Introduces SmartSuite(R) Energy Management Technology for Global Commercial, Multi-Residential and Hospitality Real Estate Market
- Kontrol Energy Corp.’s (CSE: KNR) (FSE: 1K8) Smart Energy Solutions Could Cut Cannabis Cultivation Costs
ChineseInvestors.com, Inc.’s (OTCQB: CIIX) retention of Boustead Securities LLC for its anticipated IPO of wholly owned foreign enterprise CBD Biotech will enable the company to focus on its revenue base in video and online education, investor relations services and subscription activities. At the same time, CIIX plans to secure a separate exchange listing for CBD Biotech (http://nnw.fm/373jL). Also today, the company was highlighted on MoneyTV with Donald Baillargeon. A complete menu of TV listings is available at the MoneyTV web site, http://www.moneytv.net.
Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.
Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.
At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.
CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.
The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.
Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.
In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.
ChineseInvestors.com (CIIX), closed the day's trading session at $0.49, off by 1.02%, on 126,804 volume with 62 trades. The average volume for the last 3 months is 227,751 and the stock's 52-week low/high is $0.365/$1.25.
- ChineseInvestors.com, Inc. (CIIX) Readies Spin Off of CBD Biotech Co. Ltd. Subsidiary and Retains Underwriter for IPO
- MoneyTV with Donald Baillargeon, 1/11
- 420 with CNW – Want to Make Money in 2019? Think About These 3 Cannabis Trends
FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF)
FinCanna Capital Corp. (CSE: CALI) a royalty company for the U.S. licensed medical cannabis industry, is pleased to announce that further to its news releases dated January 4 and 7, 2019, it is upsizing and closing its oversubscribed Secured Convertible Debentures (“Debentures”) financing in the amount of $2.4 million. Furthermore, the company has received firm commitments for an additional $1.25 million to close in a second tranche on or before February 8, 2019.
FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is a royalty company aiming to be the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry. Primarily focused on the burgeoning California cannabis market, FinCanna leverages extensive investment expertise and industry experience to benefit its shareholders and portfolio companies.
Medical Cannabis Market
According to Ameri Research, the global market for licensed medical cannabis is growing at a compound annual growth rate (CAGR) of more than 21%, on track to exceed $63.5 billion by 2024. Within this market, FinCanna has identified considerable opportunity in California, the fifth largest economy in the world and the largest medical cannabis market in North America. Arcview Group forecasts California’s legal cannabis industry will grow at 21.1% CAGR to $6.5 billion in 2020, generating more than $1 billion in tax revenue.
Royalty Model & Portfolio
FinCanna’s “whole capital” solution for businesses in the licensed medical cannabis sector includes the provision of capital investment for a percentage of their future revenues. The FinCanna Capital Solution utilizes a royalty arrangement to deliver capital, in order to facilitate the growth or other specific objectives of its investees, and ensure the business opportunity is optimized. This model provides an alternative or complement to debt and equity financing, allowing investees to maintain financial flexibility and control of their business rather than entering into arrangements that may include restrictive debt structures or giving up an ownership stake.
FinCanna’s portfolio includes Cultivation Technologies, Inc. (“CTI”), a team of experts from Fortune 150 agriculture, medical cannabis, law, engineering and technology companies. FinCanna is providing funding to CTI for its planned, fully entitled, large-scale indoor medical cannabis facility to be developed in Coachella, California.
CTI has established an interim medical cannabis extraction facility (the “Interim Facility”) that will produce licensed medical cannabis products until the Coachella Project is complete. CTI is currently expanding its product line, Coachella Premium, to include vaporizer cartridges. Initial market feedback gathered during the product development phase indicates that Coachella Premium’s vaporizer cartridges offer a unique proposition within the vaporizer market, one of the fastest growing verticals in the cannabis market.
The Interim Facility can process up to 6,000 pounds of biomass per month, the equivalent of approximately 3.7 million grams of raw oil per year, with room for expansion. It is expected that the completed Coachella Project will be able to process 30,000 to 50,000 pounds of biomass per month, or the equivalent of 18 million grams to 30 million grams of raw oil per year.
Additionally FinCanna has entered into a royalty agreement with Green Compliance, a provider of point-of-sale software solution (“ezGreen”) for licensed medical cannabis dispensaries and cultivators. Green Compliance helps its customers comply with both the Health Insurance Portability and Accountability Act (“HIPAA”) and State Laws by ensuring patients’ confidential data is being handled properly, helping to protect from possible security breaches and financial and criminal liability resulting from potential violations.
FinCanna has also signed binding term sheet with Oakland, California-based Gram Co Holdings, subject to due diligence by FinCanna. Gram Co is a cannabinoid research and refinement facility focused providing B2B and B2C products and services to licensed medical dispensaries, infused product manufacturers, and numerous others in the cannabis supply chain. The company is also retrofitting a large, state-of-the-art medical cannabis extraction laboratory, which is expected to be operating in 2018.
The foregoing contains forward-looking statements regarding Cultivation Technologies Inc. (“CTI”) which are subject to risks, uncertainties and contingencies which include, but are not limited to the statements relating the future construction and completion of the CTI medical cannabis facility in Coachella, California, and the projected biomass processing and raw oil production at the facility. Such forward looking statements are based on assumptions regarding the construction, completion and operations of CTI’s proposed facility, including that CTI will obtain the financing required to build and equip its proposed facility, that CTI will obtain the additional financing required operate the facility, that construction facility is completed on time and budget, that CTI obtains state licenses to operate on a permanent basis, and that the equipment used in the cultivation of medical cannabis performs at scale in a similar way it performs at CTI’s pilot tests.
FinCanna Capital Corp. (FNNZF), closed the day's trading session at $0.1043, off by 9.46%, on 60,759 volume with 22 trades. The average volume for the last 3 months is 55,421 and the stock's 52-week low/high is $0.0577/$0.8736.
- FinCanna Increases and Closes Convertible Debenture Financing of $2.4 Million
- FinCanna Increases Convertible Debenture Financing to $2.0 Million
- FinCanna Announces Convertible Debenture Financing to Raise CAD $1.5 million
BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT)
BriaCell Therapeutics (OTC: BCTXF) (TSX.V: BCT), a biotechnology company developing targeted, safe treatments for cancer, sees a promising future for its lead product candidate, Bria-IMT. To view the full article, visit: http://nnw.fm/Tm2FS.
BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT), based in Berkeley, CA, and headquartered in Vancouver, British Columbia, is a clinical-stage biotechnology company focused on the development of targeted immunotherapy for advanced breast cancer.
BriaCell hopes to develop and market the first off-the-shelf personalized immunotherapy for the treatment of advanced breast cancer.
The results of two previous proof-of-concept clinical trials produced encouraging results in patients with advanced breast cancer. Most notably, one patient with breast cancer that had spread to other sites (metastatic cancer) responded to Bria-IMT™ with a substantial tumor shrinkage in multiple sites including the breast, the lung, soft tissues and even the brain. Similar observations have been confirmed more recently in additional patients, and BriaCell is developing BriaDX™ as a way to identify those patients most likely to respond.
BriaCell has recently completed recruitment of a Phase I/II study (NCT03066947) of Bria-IMT™, the Company’s lead product candidate, in advanced breast cancer patients showing an outstanding safety profile and excellent efficacy. BriaCell is currently enrolling advanced breast cancer patients in a combination therapy trial (NCT03328026) of Bria-IMT™ with Keytruda® (Keytruda® is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.) or Yervoy® (Yervoy® is a registered trademark of Bristol-Myers Squibb Company). For further information on the Phase IIa clinical trials, please visit trial NCT03066947 and trial NCT03328026.
BriaCell’s pipeline also includes Bria-OTS™, the first off-the-shelf personalized immunotherapy for advanced breast cancer; and, a companion diagnostic product BriaDX™. By using BriaDX™ to identify and treat the patients who would most likely benefit from their immunotherapies, BriaCell expects to personalize the treatment for the patients, and bring hope to thousands of cancer patients who currently have few-to-no treatment options.
Breast Cancer Statistics
The National Cancer Institute estimates that more than 265,000 new cases of female breast cancer will be diagnosed in the U.S. during 2018, and that more than 40,000 women in the U.S. will die from the disease. Approximately 12 percent of women will be diagnosed with breast cancer at some point during their lifetime, based on 2013-2015 data.
Using its novel technology platform and strong R&D capabilities, BriaCell believes it has the opportunity to address this market, as well as have the opportunity to develop immunotherapy candidates for other cancer indications.
The global cancer immunotherapy market is expected to reach nearly USD$203 billion by 2025.
BriaCell Therapeutics Corp. (BCTXF), closed the day's trading session at $0.059825, off by 14.54%, on 5,992,366 volume with 158 trades. The average volume for the last 3 months is 10,958,619 and the stock's 52-week low/high is $0.0123/$0.16.
- NetworkNewsBreaks – BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT) Confident in the Future of Bria-IMT Following its Demonstrated Success in Clinical Trials
- BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Advances Novel Formulation of Drug Candidate in Battle against Advanced Breast Cancer
- BriaCell Announces Switch to Novel Frozen Formulation for Lead Cancer Drug Candidate, Upcoming Attendance at Biotech Showcase™ 2019 and Presentation at Keystone Symposia Conference
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- Aziza Project LLC, Investing in Operations in the Southern Africa Region
- BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT) Advances Novel Formulation of Drug Candidate in Battle against Advanced Breast Cancer
- Cannabis Strategic Ventures, Inc. (NUGS) Submits Application to Uplist to OTCQB® Venture Market
- Canopy Rivers Inc. (TSXV: RIV) Announces Investment in Technology Driven Data Company Headset
- ChineseInvestors.com (CIIX) 420 with CNW – Want to Make Money in 2019? Think About These 3 Cannabis Trends
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) ParcelPal CEO Kelly Abbott Provides a Corporate Update
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Cyberfort Software, Inc. (CYBF) Offers Tech Armory to Fight Off Ad Attack
- DPW Holdings, Inc. (NYSE American: DPW) Subsidiaries Receive Debt Financing to Decrease Defense Sector Order Backlog
- Earth Science Tech, Inc. (ETST) Announces Strategic Partnerships to Market Hygee™ and Address Global Epidemic
- FinCanna Capital Corp. (CSE: CALI) (OTC: FNNZF) Increases Convertible Debenture Financing to $2.0 Million
- First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF) Begins Permitting and Environmental Programs at Iron Creek
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Eye-Net Mobile Successfully Completes Initial Integration with the Assistance of a Leading Israeli Cellular Provider
- Generation Alpha, Inc. (GNAL) 420 with CNW – Mexico to Consult Other Countries on Cannabis Legalization, Minister Reveals
- Global Payout, Inc. (GOHE) and MTrac Begin POS Integrations to Drive Paradigm Shifts, Mass Market Adoption
- Golden Developing Solutions, Inc. (DVLP) 420 with CNW – Arkansas Delays Issuing Medical Cannabis Cards
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) Partners with DSW to Sell Seventh Sense CBD Products
- Green Hygienics Holdings Inc. (GRYN) 420 with CNW – Arkansas Delays Issuing Medical Cannabis Cards
- GTX Corp (GTXO) Secures a $500,000 Revolving Line of Credit for Product Financing and Signs up Two New Distributors
- Icon Exploration Inc. (TSX.V: IEX.H) Building Presence in Booming Cannabis Space
- Kontrol Energy Corp. (CSE: KNR) (OTC: OTSHF) (FSE: 1K8) Introduces SmartSuite(R) Energy Management Technology for Global Commercial, Multi-Residential and Hospitality Real Estate Market
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) Exclusive Interview: Lexaria CEO Discusses Progress & Plans at O’Cannabiz 2018 -- CFN Media
- Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF) Enhances Technical Team and Board of Directors; Appoints Leading Lithium Expert, and Grants Stock Options
- Marijuana Company of America Inc. (MCOA) Clone Production at Marijuana Company of America’s Scio Oregon Hemp Project Underway – Hemp Growers License Renewed for 2019
- Medical Cannabis Payment Solutions (REFG) 420 with CNW – CARERS Act Seeks to Reform Federal Marijuana Law
- Net Element, Inc. (NASDAQ: NETE) Asset Acquisitions Grant New Potential to Payment Technology Developer
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) NetworkNewsWire Announces Publication on Multinational Companies and Industrialized Nations Working to Secure Critical Metals
- Pacific Software, Inc. (PFSF) Issues Update on Launch of E-Commerce Trade Platform
- Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF) Applauds the Passing of the 2018 Farm Bill; Appoints New Member to Board of Directors
- Plus Products Inc. (CSE: PLUS) 420 with CNW – Rhode Island Considers Using Medical Cannabis to Stop Opioid Dependency
- Pressure BioSciences Inc. (PBIO) Announces Commercial Launch of its Unique Biopharmaceuticals Contract Services Business
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Receives Positive Results from the MMI Geochemical Orientation Survey Over the Irgon Dike; Two Additional Targets Identified
- Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) 420 with CNW – Rhode Island Considers Using Medical Cannabis to Stop Opioid Dependency
- Sharing Services, Inc. (SHRV) Names Multilingual Direct-Selling Marketing Leader Clare Holbrook as Chief Marketing Officer of Elepreneur, LLC.
- SinglePoint, Inc. (SING) SinglePoint Looks Ahead to 2019 Highlighting Company Direction and Acquisitions
- Spectrum Global Solutions, Inc. (SGSI) CEO Interviewed on the RedChip Money Report
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) Building Cannabis-Infused Beverage Solutions with Leadership Depth
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) Makes First Pilot-Scale Battery Quality Lithium Carbonate, Engages Investor Relations Firm, LHA
- Sugarmade, Inc. (SGMD) Stands Firm in its Commitment to Supply the Legal Cannabis Cultivation Industry
- Sunniva, Inc. (CSE: SNN) (OTC: SNNVF) Secures Over $2.4M in Initial Cannabis Product Sales in California
- Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) Inks Consulting Agreement with Khalifa Kush Enterprises
- Teewinot Life Sciences Produces Cannabinoids through Patent-protected CANNSYNTHESIS Technology - QualityStocksNewsBreaks
- The Flowr Corp. (TSX.V: FLWR) Identifies Acquisition of Stake in Holigen as ‘Transformative Transaction’
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) Adds Deep Medical and Pharmaceutical Experience to its Board of Directors with Appointment of Two New Directors
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Sees Opportunity in Applying Novel Skin Remedies to Health Concerns
- TransCanna Holdings Inc. (CSE: TCAN) Closes IPO Generating $2.2M in Gross Proceeds
- United Battery Metals Corp. (CSE: UBM) (OTC: UBMCF) (FWB: 0UL) Retracts Technical Disclosures
- Victory Marine Holdings Corp. (VMHG) Aims to Offer Tailored Customer Care Following Sales
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Announces Appointment of Dr. Richa Love as Chief Medical Officer
- Youngevity International, Inc. (NASDAQ: YGYI) CLR Roasters Ships First 3.8 Million Pounds of Green Coffee Under its 5-Year Estimated $250 Million Green Coffee Contract
- Zenergy Brands, Inc. (ZNGY) Builds Consumers’ Capacity to Efficiently Manage Utilities Use While Conserving the Environment
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.